Plasma Cell precursor and Other Disorders
Ibrutinib plus rituximab versus ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysis of three prospective studies
Jorge J. Castillo, MD (he/him/his)
Associate Professor of Medicine
Dana-Farber Cancer Institute
Boston, Massachusetts, United States